This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Solomon H. Snyder, MD

Arch Gen Psychiatry. 1972;27(2):169-179.

Abstract
Amphetamine psychosis appears to be a fruitful experimental model of paranoid schizophrenia or paranoid state. A variety of animal and human studies suggest that neurochemical mediation of certain behavioral effects of amphetamine in animals may reflect such mechanisms in human amphetamine psychosis. Specifically, locomotor stimulation appears attributable to central norepinephrine and stereotyped behavior to dopamine, while experiments with amphetamine isomers in man suggest a dopamine mediation of human amphetamine psychosis.

Pharmacological and stereochemical evidence suggests that clinical efficacy of phenothiazine drugs in the treatment of schizophrenia may be related to blockade of dopamine receptors. Taken together, these findings provoke the speculation that specific and distinct effects of amphetamines on dopamine and norepinephrine neurons may combine to account for major symptoms of amphetamine psychosis.

Author Affiliations
Baltimore

From the Department of Pharmacology and Experimental Therapeutics, Johns Hopkins University School of Medicine, Baltimore.

Footnotes
Accepted for publication Dec 1, 1971.

Reprint requests to 725 N Wolfe St, Baltimore, Md 21205 (Dr. Snyder).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Identification of Functional Polymorphisms in the Promoter Region of the Human PICK1 Gene and Their Association With Methamphetamine Psychosis
Matsuzawa et al.
Am. J. Psychiatry 2007;164:1105-1114.
ABSTRACT | FULL TEXT  

Dopaminergic Control of Sleep-Wake States
Dzirasa et al.
J. Neurosci. 2006;26:10577-10589.
ABSTRACT | FULL TEXT  

Low Muscarinic Receptor Binding in Prefrontal Cortex From Subjects With Schizophrenia: A Study of Brodmann's Areas 8, 9, 10, and 46 and the Effects of Neuroleptic Drug Treatment
Crook et al.
Am. J. Psychiatry 2001;158:918-925.
ABSTRACT | FULL TEXT  

Dopamine D2 Long Receptor-Deficient Mice Display Alterations in Striatum-Dependent Functions
Wang et al.
J. Neurosci. 2000;20:8305-8314.
ABSTRACT | FULL TEXT  

Lamina-Specific Alterations in the Dopamine Innervation of the Prefrontal Cortex in Schizophrenic Subjects
Akil et al.
Am. J. Psychiatry 1999;156:1580-1589.
ABSTRACT | FULL TEXT  

Stimulant-induced disruption of non-human primate social behavior and the psychopharmacology of schizophrenia
Schlemmer et al.
J Psychopharmacol 1996;10:64-76.
 

Dopamine Agonist Treatment of Schizophrenia With N-Propylnorapomorphine
Tamminga et al.
Arch Gen Psychiatry 1986;43:398-402.
ABSTRACT  

Trazodone--Oral Cocaine Interactions
Rowbotham et al.
Arch Gen Psychiatry 1984;41:895-899.
ABSTRACT  

Pimozide blocks establishment but not expression of amphetamine-produced environment-specific conditioning
Beninger and Hahn
Science 1983;220:1304-1306.
ABSTRACT  

Coping and the stress-induced potentiation of stimulant stereotypy in the rat
MacLennan and Maier
Science 1983;219:1091-1093.
ABSTRACT  

Schizophrenia: elevated cerebrospinal fluid norepinephrine
Lake et al.
Science 1980;207:331-333.
ABSTRACT  

Long-term amphetamine treatment decreases brain serotonin metabolism: implications for theories of schizophrenia
Trulson and Jacobs
Science 1979;205:1295-1297.
ABSTRACT  

Long-term changes in dopaminergic innervation of caudate nucleus after continuous amphetamine administration
Ellison et al.
Science 1978;201:276-278.
ABSTRACT  

Potent antidopaminergic activity of estradiol at the pituitary level on prolactin release
Raymond et al.
Science 1978;200:1173-1175.
ABSTRACT  

Schizophrenic symptoms improve with apomorphine
Tamminga et al.
Science 1978;200:567-568.
ABSTRACT  

Chronic, Multiple Tics of Gilles de la Tourette's Disease: CSF Acid Monoamine Metabolites After Probenecid Administration
Cohen et al.
Arch Gen Psychiatry 1978;35:245-250.
ABSTRACT  

Effects of Isometric Exercise on Serum Creatine Phosphokinase Activity
Goode and Meltzer
Arch Gen Psychiatry 1976;33:1207-1211.
ABSTRACT  

Variability in Schizophrenia: Reflection of a Regulatory Disease
van der Velde
Arch Gen Psychiatry 1976;33:489-496.
ABSTRACT  

Cocaine: plasma concentrations after intranasal application in man
Van Dyke et al.
Science 1976;191:859-861.
ABSTRACT  

Sympathomimetics and Schizophrenia
HANSELL
JAMA 1975;234:1220-1220.
ABSTRACT  

Cerebrospinal Fluid Amine Metabolites in Acute Schizophrenia
Post et al.
Arch Gen Psychiatry 1975;32:1063-1069.
ABSTRACT  

Amphetamine-Induced Dopaminergic Hypersensitivity in Guinea Pigs: Implications in Psychosis and Human Movement Disorders
Klawans and Margolin
Arch Gen Psychiatry 1975;32:725-732.
ABSTRACT  

Haloperidol for Acute Amphetamine Poisoning: A Study in Dogs
Catravas et al.
JAMA 1975;231:1340-1341.
ABSTRACT  

Ethanol, Methamphetamine, Pentobarbital
Crowley et al.
Arch Gen Psychiatry 1974;31:829-838.
ABSTRACT  

Serum Prolactin Levels in Unmedicated Schizophrenic Patients
Meltzer et al.
Arch Gen Psychiatry 1974;31:564-569.
ABSTRACT  

Central Dopamine Turnover in Schizophrenic Syndromes
Bowers
Arch Gen Psychiatry 1974;31:50-54.
ABSTRACT  

Antischizophrenic Drugs and Brain Cholinergic Receptors: Affinity for Muscarinic Sites Predicts Extrapyramidal Effects
Snyder et al.
Arch Gen Psychiatry 1974;31:58-61.
ABSTRACT  

Dopamine Nerve Terminals in the Rat Limbic Cortex: Aspects of the Dopamine Hypothesis of Schizophrenia
Hokfelt et al.
Science 1974;184:177-179.
ABSTRACT  

Amphetamine in Human Plasma: A Sensitive and Specific Enzymatic Assay
Kreuz and Axelrod
Science 1974;183:420-421.
ABSTRACT  

Catecholamine Uptake in Cerebral Cortex: Adaptive Change Induced by Fighting
Henley et al.
Science 1973;180:1050-1052.
ABSTRACT  

Reduced Monoamine Oxidase Activity in Platelets: A Possible Genetic Marker for Vulnerability to Schizophrenia
Wyatt et al.
Science 1973;179:916-918.
ABSTRACT